Ridaforolimus
CAS: 572924-54-0
Ref. TM-T6334
| 5mg | 55.00 € | ||
| 10mg | 88.00 € | ||
| 25mg | 159.00 € | ||
| 50mg | 278.00 € | ||
| 1ml*10 (DMSO) | 92.00 € |
Product Information
- AP23573, Deforolimus, MK-8669
- 42-(Dimethylphosphinate)rapamycin
- Ap 2357
- Ap 23573
- Mk 8669
- Rapamycin, 42-(dimethylphosphinate)
Ridaforolimus (AP23573) is a small molecule and non-prodrug analogue of the lipophilic macrolide antibiotic rapamycin with potential antitumor activity. Ridaforolimus binds to and inhibits the mammalian target of rapamycin (mTOR), which may result in cell cycle arrest and, consequently, the inhibition of tumor cell growth and proliferation. Upregulated in some tumors, mTOR is a serine/threonine kinase involved in regulating cellular proliferation, motility, and survival that is located downstream of the PI3K/Akt signaling pathway.
Chemical properties
Technical inquiry about: TM-T6334 Ridaforolimus
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
